Skip to main content
. 2021 Sep 27;23(9):e28355. doi: 10.2196/28355

Table 2.

Comparison of attitudes toward human papillomavirus vaccination and screening tests according to intervention.

Variable All (N=1660), n (%) Intervention (n=830), n (%) Control (n=830), n (%) Yes response vs other




ORa (95% CI) P valueb Adjusted ORc (95% CI) P valueb
Q6. If you have/had a daughter, do/would you consider getting her vaccinated against HPVd?

Yes 352 (21.2) 196 (23.6) 156 (18.8) 1.34 (1.05-1.69) .02 1.32 (1.04-1.69) .02

No 240 (14.5) 115 (13.9) 125 (15.1)




I’m not sure 1068 (64.3) 519 (62.5) 549 (66.1)



Q7. If you have/had a son, do/would you consider getting him vaccinated against HPV?

Yes 273 (16.4) 153 (18.4) 120 (14.5) 1.34 (1.03-1.74) .03 1.38 (1.05-1.80) .02

No 254 (15.3) 127 (15.3) 127 (15.3)




I’m not sure 1133 (68.3) 550 (66.3) 583 (70.2)



Q8. Would you consider undergoing a pape smear? If male, will you want your family or partner to have a smear?

Yes 1186 (71.4) 601 (72.4) 585 (70.5) 1.10 (0.89-1.36) .39 1.10 (0.89-1.37) .37

No 474 (28.6) 229 (27.6) 245 (29.5)



Q9. Would you undergo the cancer screening tests recommended by the government?

Yes 1128 (68.0) 574 (69.2) 554 (66.7) 1.12 (0.91-1.37) .29 1.12 (0.91-1.38) .30

No 532 (32.0) 256 (30.8) 276 (33.3)



Q10. Do you plan informing family members, friends, or others about cancer prevention and screening (through Facebook, LINE, Twitter, etc)?

Yes 760 (45.8) 396 (47.7) 364 (43.9) 1.17 (0.96-1.42) .12 1.15 (0.94-1.40) .17

No 900 (54.2) 434 (52.3) 466 (56.1)

aOR: odds ratio.

bP value estimated using binomial logistic regression analysis.

cQ2, Q4, and Q5 were included as covariates in the adjusted OR.

dHPV: human papillomavirus.

ePap: Papanicolaou test.